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Abstract. We consider a simple one-dimensional time-dependent mod-
el for bone regeneration in the presence of a bio-resorbable polymer
scaffold. Within the framework of the model, we optimize the effective
mechanical stiffness of the polymer scaffold together with the regener-
ated bone matrix. The result of the optimization procedure is a scaffold
porosity distribution which maximizes the stiffness of the scaffold-bone
system over the regeneration time, such that the propensity for mechan-
ical failure is reduced.
1. Introduction
The regeneration and restoration of skeletal functions of critical-sized
bone defects are very challenging. Presently, regenerative therapy using
biodegradable scaffolds have shown promising results in vivo [BRW+13,
CRE+13, RWC+11, SSS+09, RHL+07] and in clinical cases [IG07, HSG16,
TTL+15, SJT08]. During the bone regeneration processes, scaffolds act as a
temporary supporting structure to (a) ensure that the defect/regeneration
space is suitable for bone tissue growth, maturation and remodeling; (b)
provide mechanical functionality for proper transfer of loads acting on scaf-
folds to the adjacent host tissues while tissue regenerates; and (c) facili-
tate in-growth of tissue and vasculature to accelerate tissue regeneration.
Hence, the scaffolds’ architecture plays a crucial role during bone regener-
ation processes. Fundamentally, in the design of bone scaffolds, there are
several functional characteristics to be considered, such as the porosity (or
biomaterial volume fraction), pore size and pore shape, as these will affect
the scaffolds’ permeability/diffusivity, degradation rate and elastic modulus,
and in turn the biological processes necessary for regeneration [PCW+16].
Due to the intricate relationships between scaffold geometries, mechani-
cal properties, biomaterials and biological processes, research in bone tissue
engineering has been dominated by trial-and-error approach—whereby an
existing design is modified based on the experimental outcomes. This ap-
proach usually requires costly protocols and time-consuming experiments.
Over the years, due to rapid development of computer-aided engineering
(CAE) tools, topology optimization techniques have shown their potential
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as a powerful tool for the design of scaffolds’ architecture. Topology opti-
mization is a numerical process to iteratively distribute a given amount of
material within a given design space under specific constraints such that the
final structure meets specific design targets [All12, BS13]. This technique
has been applied to design scaffolds to topologically achieve the optimized
architecture to match the desired porosity, elastic modulus and fluid perme-
ability [DGF+14, CHFF15, LKH04, GP06, CGGR12, KLH10].
One limitation common to most CAE models for topology optimization
of bone scaffolds architectures is that the time-dependence of the regenera-
tion process is not taken into account. Bone regeneration using scaffolds is a
complex phenomenon which involves different biophysical processes and scaf-
fold/tissue interactions via their elastic moduli over time. To this end, var-
ious multi-scale models have been proposed and developed simulating bone
regeneration processes in response to various scaffolds properties (i.e., poros-
ity, permeability, elastic modulus), taking into account the time-evolution of
the microstructure due to bone growth and scaffold resorption [SHGAD08].
Hollister et al. [HMT02] proposed a topology optimization approach that
can design a scaffold microstructure in order to meet the resulting conflict-
ing design requirements.
However, implementation of CAE into routine additive manufacturing
(AM) workflows for optimization of scaffolds for regenerative medicine is
impeded by the high computational cost. Here, we propose a simple, one-
dimensional model for the optimization of bone scaffold architectures based
on homogenized quantities. The main advantage of this model will be its
efficiency for numerical computation. We can therefore use it as a first test
case for a scaffold shape-optimization procedure, in particular with respect
to finding suitable objective functions to optimize. Our approach is thus
related to the first step in the “Shape Optimization by the Homogeniza-
tion Method” [All12] of optimizing within a relaxed problem for averaged
quantities.
The remainder of this article is organized as follows. In section 2 we
introduce our simplified bone regeneration model and show some comparison
to in-vivo studies. Section 3 describes the numerical optimization routine.
The results of our numerical experiments are presented in section 4. Finally
in section 5 we discuss conclusions and give an outlook to future work.
2. Development of a scaffold-mediated bone regeneration
model
In bone tissue engineering, the process of bone regeneration is commonly
mediated by osteoconductive scaffolds that are often combined with growth
factors and/or cells (osteoinductive). However, the exact mechanism by
which scaffold-mediated bone regeneration occurs is yet unclear. The pro-
cess of bone regeneration is a complex and continuous process, but well
orchestrated, starting from the formation of hematoma accompanied by the
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infiltration of inflammatory cells. Following the events of inflammation,
bone regeneration can occur through either endochondral (bone formation
through an intermediate cartilage phase) or intramembranous ossification
(formation of new bone directly - usually occuring adjacent to existing
bone). Finally, the regenerating bone enters the remodeling stage, where
newly formed bone continues to remodel itself until a mechanically strong
and highly organized bone structure is restored. The specific mechanism
of bone regeneration is determined by the immediate biomechanical and
chemical environment where the cell resides. For example, studies of bone
regeneration mediated by scaffolds made from a composite of polycapro-
lactone (PCL, a slow degrading synthetic thermoplastic) and β-tricalcium
phosphate (β-TCP) illustrated that porous scaffolds support formation of
a structured fibrous tissue across the defect, which acts as the supporting
network guiding the mineralization process and bone in-growth through the
depth of the defect [CLS+12]. More recently, a follow-up study revealed a
non-standard form of mineralization of extracellular matrix within a porous
scaffold, whereby extracellular matrix (ECM) mineralization occurs with-
out collagen remodeling and without an intermediate cartilage ossification
phase, extending from the proximal and distal end of the osteotomy site
parallel to the tibia axis [PGH+17]. In both studies [CLS+12, PGH+17],
it was noted that in the absence of exogenous growth factors or cells, no
clinically relevant bridging of the defect was achieved.
In this study, the primary intention of the proposed scaffold-mediated
bone regeneration model is to provide a basis for the scaffold architecture
optimization algorithm proposed in section 3. Hence, we propose a sim-
ple mathematical model capturing specific events occurring during the pro-
cess of scaffold-mediated bone regeneration. However, the model does take
into consideration the time-aspect of tissue regeneration, considering both
bone growth and scaffold degradation and the interaction of the two. The
time evolution model tracks the time dependent quantities that are rele-
vant for the mechanical integrity of the scaffold. These quantities are the
molecular weight of the scaffold material (which diminishes over time due
to degradation) and the amount of bone regenerated. The bone regenera-
tion, however, depends on the local microenvironment. This includes (a) the
presence of endogenous angiogenic and osteoinductive factors (e.g., growth
factors/cytokines), which are excreted into, diffuse through, and decay in
the extracellular matrix in the interstitial space creating a local gradient
through the regenerating tissue; and (b) the mechanical strain stimulus
transmitted through the structure due to external mechanical loading as
it is well established that mechanical stimuli play a major role in bone re-
generation [GCV+17].
A coupled system of evolution equations for these quantities, together
with boundary conditions, has been established and constants in the model
(e.g., the degradation rate of the scaffold material) have been deduced from
experimental observations. We note that the model does not resolve these
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quantities on a fine (µm) scale, but uses coarse-grained values. The spatial
domain of computation is the domain occupied by the scaffold. We simplify
this domain to a one-dimensional object by only considering one of the main
stress axis under physiological mechanical loading.
Concretely, we solve the following system of differential equations (in
space on the domain (0, L) and time for t ∈ (0, T ]) for the scaffold volume
fraction ρ = 1− θ with θ being the scaffold porosity, the relative molecular
weight of the scaffold material σ (normalized to be equal to unity for a
new scaffold), the relative bone density b, the density of active biological
molecules (osteoinductive factors) a, and the mechanical displacement u:
ρt = 0 (occupied space does not change in time)
σt = −k1σ (exponential loss of molecular weight)
at = (D(ρ)ax)x + k2|ux|b− k3a (diffusion, generation, and decay ofactive molecules)
0 = (C(ρ, σ, b)ux)x (mechanical equilibrium)
bt = k4a|ux|
(
1− b
1− ρ
) (bone growth proportional to a and
mechanical strain but constrained by
free volume)
In this system, k1, k2, k3 and k4 are constant parameters, D, and C are
functional relationships, all to be determined by experiment.
This model assumes PCL as the scaffold material. In vivo, PCL showes
a two-stage degradation pattern, predominantly by bulk erosion. The first
stage involves a decrease in molecular weight (Mw) without volume loss.
The second stage of degradation begins when the Mw drops below 8000 Da,
at which the material becomes brittle and loss of volume occurs [SMS+06],
but this happens past the time scale considered here. Therefore, we consider
no loss of volume fraction of the scaffold material to occur over time.
The initial and boundary conditions for the respective variables are given
by
ρ(x, 0) = ρ0(x) for all x ∈ (0, L)
σ(x, 0) = 1 for all x ∈ (0, L)
a(x, 0) = 0 for all x ∈ (0, L)
a(0, t) = a(L, t) = 1 for all t ∈ [0, T ]
u(0, t) = 0, u(L, t) = γL for all t ∈ [0, T ]
b(x, 0) = 0 for all x ∈ (0, L),
i.e., in the beginning, the scaffold is fully intact, and no regenerated bone
is present. The bone adjacent to the scaffold, however, produces the active
molecules such that saturation is achieved there. The value for u(L, t) was
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T 12 months
L 30mm
γ 1%
D(ρ) k5(1− ρ)
C(ρ, σ, b) ρσ + k6b
k1 0.1 per month
k2 80/γ per month
k3 80 per month
k4 0.25/γ per month
k5 100(µm)
2/s ≈ 260(mm)2/month
k6 9.0
Table 1. Parameters used for the bone regeneration model
chosen such that the scaffold is subject to a hard-loaded engineering strain
γ∗.
The resulting evolution equations are solved using established numerical
methods, in our case, an implicit first-order Euler scheme. Due to the coarse
graining of the relevant variables in the model, such a computation can be
done in a very short time.
The parameters used for the model can be found in Table 1. The re-
generation time and the length of the scaffold were chosen to model a re-
alistic critical size bone defect, as for example studied in an ovine model
in [CWZ+15]. The hydration rate constant k1 is set to be consistent with
findings in the literature that after one year approximately 30% of the orig-
inal molecular weight remains [PCH+81]. The diffusivity constant, k5 in D,
is a standard value for the diffusion of water soluble proteins [BKG+12],
with the ρ-dependent prefactor we account for the increased tortuosity of
the microscopic diffusion domain due to the scaffold. The constants k2, k3,
and k4 are set such that a realistic regeneration outcome is achieved, see for
example Figure 1(a) and compare to [CWZ+15, Fig. 2(B), scaffold only],
where the amount of regrown bone in the central region is approximately 75
mm3, which for a sample diameter of 20 mm and height of 1 mm corresponds
to approximately 25% of regenerated bone matrix for a scaffold density of
approximately ρ0 = 13%. The relative modulus of bone vs. scaffold, k6, is
chosen to agree with measurements (i.e, the ratio of the nano-indentation
hardness for regenerated bone [CWZ+15, Fig. 8(C), scaffold only] of 0.64
GPa and the nano-indentation hardness for PCL [LXQ+18, Table 5]) of 0.071
GPa. For the elastic modulus C we use the Voigt Bound for composites.
∗We note that the magnitude of the displacement boundary condition is arbitrary and
could be normalized to unity by changing the parameter k4. Furthermore, the displace-
ment u is non-dimensionalized.
6 PSP POH, D VALAINIS, K BHATTACHARYA, M VAN GRIENSVEN, AND P DONDL
0 5 10 15 20 25 30
x (mm)
0
0.1
0.2
0.3
0.4
0.5
0.6
b 
(a
t t
=
12
 m
on
th
s)
0
 = 0.13
0
 = 0.75
(a) Relative bone density at t=12
months with initial condition ρ0 = 0.1
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(b) Time evolution of the effective elas-
tic modulus, normalized to the elastic
modulus of PCL.
Figure 1. Outcome of the model without optimization.
We note that our model includes local production of bioactive molecules
only. An addition of a bone growth booster in the model could be imple-
mented by changing the initial conditions for the function a. However, min-
imizing the required booster does have advantages in particular for patients
suffering from bone cancer.
In order to obtain a numerical approximation to the solution of our model,
we employ a simple first-order-in-time Euler scheme, where in each time step
the discrete equations are solved in the order that they are displayed above
(with current values for the quantities substituted in each equation), and are
thus decoupled. The diffusion equation for a as well as the elliptic equation
for u are discretized in space using piecewise affine finite elements. The
resulting ordinary differential equations for σ and a are discretized implicitly
in time, the equation for b is discretized explicitly in time. The time-step is
0.1 months and the spatial discretization length is 0.4mm.
The resulting regenerated bone matrix for the given parameters and two
different constant values for ρ0 are shown in Figure 1(a). We note that an
overly high volume fraction of scaffold material inhibits bone regeneration
in our model, which is indeed an observed phenomenon.
3. The optimization algorithm
Using current additive manufacturing technologies, it is possible to gen-
erate unit-cell based scaffolds with any given porosity distribution ρ0 on the
domain occupied by the implant. We note that this distribution of porosity
is a major aspect of the scaffold architecture. The solution of the evolu-
tion equations in our model now allows the deduction of, for example, the
rate of proliferation of newly generated bone matrix within the implant, all
dependent on the initial scaffold porosity distribution.
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The model above can furthermore be used to evaluate the time evolution
of the mechanical stiffness (i.e., effective elastic modulus of the structure
stemming from both the scaffold material and the regenerated bone) of the
implant for a given ρ0. This mechanical stiffness is (in our case) proportional
to the total elastic energy in the system at time t ∈ [0, T ],
Eel(t) = inf
v∈H1((0,L))
v(0)=0,v(L)=γL
∫ L
0
vxC(ρ(x, t), σ(x, t), b(x, t))vx dx,
where ρ, σ, and b follow the equations above (and thus depend on ρ0).
Figure 1(b) shows the evolution of E in time for the two unoptimized test
cases.
It is possible to maximize the minimum over the regeneration time of the
overall mechanical stiffness
Emin(ρ0) = min
t∈[0,T ]
Eel(t)
of the scaffold among all physiologically suitable (i.e., with a cutoff to ensure
ρ0(x) ≤ 0.7 in order to not prevent vascularization) initial scaffold porosity
distributions.
It is important to note that for PCL scaffolds such an optimization is a
reasonable approach. For certain titanium-mesh scaffolds it has been found
that softer scaffolds yield better regeneration results [PCR+18]—PCL, how-
ever, is already a material that is less stiff than bone. Therefore, it is not an
issue here to obtain the mechanical stimulus that is required for bone regen-
eration. Instead, the main drawback of PCL scaffolds is their potential for
mechanical failure, which can be minimized by maximizing their mechanical
stiffness.
We achieve this with the established method of using a gradient flow type
optimization of the objective function Emin. To be more precise, we calcu-
late an approximation of the Fre´chet derivative δρ0E
min(ρ0) by using finite
differences in each node of the spatial discretization. Then a gradient ascent
with a soft pointwise constraint on the volume fraction is performed. The
computational cost for such an optimization method is easily manageable
due to the use of coarse grained values in the evolution equation system.
Our MATLAB implementation performs a full optimization and reaches a
stationary state of the gradient ascent in a few minutes on a regular desktop
computer, thus more sophisticated methods were not deemed necesseary.
Our method can therefore yield an optimized scaffold design, adapted to a
given mechanical load and other (possibly patient specific) parameters.
4. Numerical Results
Figure 2 shows a comparison of the optimized scaffold designs. Table 2
shows the minimal elastic modulus values for all designs. In particular, we
also compare the optimization among constant-volume fraction scaffolds.
In our model, with the parameters given in Table 1, the difference in the
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(b) Time evolution of the normalized ef-
fective elastic modulus depending on ρ0.
Figure 2. Comparison of scaffold optimization results.
ρ0 = 0.13 0.13
ρ0 = 0.75 0.45
Optimization among constant ρ0 0.50
Full optimization 0.54
Optimization among constant ρ0 (reduced bone regeneration) 0.26
Full optimization (reduced bone regeneration) 0.36
Reduced bone regeneration but ρ0 optimized for regular patient 0.28
Table 2. Comparison of minimal elastic modulus Emin(ρ0)
for the scaffold designs under consideration. The values are
normalized such that the scaffold material PCL has an elastic
modulus of 1.
minimal elastic modulus between the full optimization and the optimization
restricted to constant volume fractions is approximately 8%. In particular,
we see that the optimal scaffold is denser in the middle region—this can
of course be understood from heuristic arguments: the regenerated bone
grows back from the ends where the scaffold is attached to the intact bone
matrix. Thus, in the central region, the scaffold polymer has to maintain
the structural integrity for a longer time by itself, while undergoing bulk
erosion.
Furthermore, we conducted a numerical experiment where the bone-re-
generation coefficient was reduced to k4 = 0.125/γ and the stiffness ratio
k6 = 4.5, to emulate a patient with reduced regeneration capacity, for ex-
ample due to osteoporosis. Table 2 shows that the difference between the
full optimization and the optimization among constant ρ0 grows to nearly
40% in this case. We also note that the scaffold optimized for the ‘regular’
value of k4 and k6 is far from optimal for reduced bone regeneration. The
optimized ρ0 and corresponding elastic moduli are plotted in Figure 3.
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(a) Optimized volume fraction distribu-
tions.
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(b) Time evolution of the normalized ef-
fective elastic modulus depending on ρ0.
Figure 3. Comparison of scaffold optimization results for
the model with reduced bone regeneration, i.e., k4 = 0.125/γ
and k6 = 4.5.
5. Conclusions
We have devised a simple model for bone regeneration that is suitable for
use in an optimization routine for polymer bone scaffolds. As a proxy for
the mechanical stability of such scaffolds, we maximize the effective elas-
tic modulus of the combination of scaffold- and regenerated bone material,
after taking its minimum over the regeneration time. With this method,
it is possible to find optimized volume fraction distributions for additively
manufactured scaffolds based, e.g., on periodic unit cell designs. Within
our model, compared to an optimization among only constant volume frac-
tions, a small increase of 8% for the objective function can be achieved by
optimizing among non-constant initial volume fraction distributions.
We remark that, of course, our model is very simplistic and a number of
parameters are not known very exactly. However, the general outcome of
optimal scaffold designs that increase their volume fraction in their central
region (in order to provide more stability until the regenerated bone reaches
the center) and decrease their volume fraction at the edges (in order to not
impede bone-ingrowth) holds for a large range of different parameters.
In a test case with reduced bone regeneration ability, the difference is
significantly increased. This shows that our model can benefit tremendously
from patient-specific parameters to produce patient-specific optimal scaffold
designs.
Presently, diagnosis of bone defects is highly dependent on X-ray micro-
graphs, which only provide visual guidance for treatment and management
but lack precise information on the patient’s intrinsic bone regeneration ca-
pability. Potentially, this could be overcome by leveraging on Omics technol-
ogy and multi-model analysis through bioinformatics techniques to improve
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patient stratification in term of intrinsic bone regeneration capability while
unraveling the underlying biological mechanisms that govern the bone re-
generation cascade. The inclusion of such patient-specific parameters would
significantly improve the herein proposed optimization model for person-
alized bone scaffold designs. Nonetheless, such an endeavor will require
long-term synergistic and complementary research efforts across multitude
of disciplines.
Hence, within the scope of design optimization model, future work in-
cludes a refinement of the model in order to be better aligned with experi-
mental results as well as an extension to a full three-dimensional optimiza-
tion.
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